The following 17 USD investments were led by Mr. Shuhua Zhou and Ms. Karen Liu prior to the founding of Kaiwu Capital. 16 of these investments were led by Mr. Zhou and Ms. Liu while they were at their previous firms, Northern Light Venture Capital (NLVC) and China Renaissance Capital Investment (CRCI), respectively.
A medical device company developing the world’s “best in class” next generation coronary drug-eluting stent for the China market
A surgical device company developing open, endoscopic and energy-based surgical devices for China and other developing markets
A specialty pharmaceutical company focused on developing and marketing generic injectable pharmaceutical products
A pharmaceutical fine chemical and API product company with a unique chemistry technology platform
A China-based CRO company offering a range of pre-clinical biological and integrated drug discovery services to the world’s leading pharmaceutical companies
A drug development company that develops first-in-class therapeutics targeting cancer stemcells for a number of cancer indications